BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23416702)

  • 1. Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction.
    Shi L; Cui S; Engel JD; Tanabe O
    Nat Med; 2013 Mar; 19(3):291-4. PubMed ID: 23416702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model.
    Rivers A; Vaitkus K; Ruiz MA; Ibanez V; Jagadeeswaran R; Kouznetsova T; DeSimone J; Lavelle D
    Exp Hematol; 2015 Jul; 43(7):546-53.e1-3. PubMed ID: 25931013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxymethylcytosine and demethylation of the γ-globin gene promoter during erythroid differentiation.
    Ruiz MA; Rivers A; Ibanez V; Vaitkus K; Mahmud N; DeSimone J; Lavelle D
    Epigenetics; 2015; 10(5):397-407. PubMed ID: 25932923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
    Ali H; Khan F; Musharraf SG
    Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
    Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D
    Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction.
    Khan F; Ali H; Musharraf SG
    Exp Cell Res; 2020 Sep; 394(2):112168. PubMed ID: 32653411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease.
    Cui S; Engel JD
    Adv Exp Med Biol; 2017; 1013():177-202. PubMed ID: 29127681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia.
    Mettananda S; Fisher CA; Sloane-Stanley JA; Taylor S; Oppermann U; Gibbons RJ; Higgs DR
    Haematologica; 2017 Mar; 102(3):e80-e84. PubMed ID: 27810991
    [No Abstract]   [Full Text] [Related]  

  • 9. Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors.
    Dulmovits BM; Appiah-Kubi AO; Papoin J; Hale J; He M; Al-Abed Y; Didier S; Gould M; Husain-Krautter S; Singh SA; Chan KW; Vlachos A; Allen SL; Taylor N; Marambaud P; An X; Gallagher PG; Mohandas N; Lipton JM; Liu JM; Blanc L
    Blood; 2016 Mar; 127(11):1481-92. PubMed ID: 26679864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plastrum testudinis induces γ-globin gene expression through epigenetic histone modifications within the γ-globin gene promoter via activation of the p38 MAPK signaling pathway.
    Qian X; Chen J; Zhao D; Guo L; Qian X
    Int J Mol Med; 2013 Jun; 31(6):1418-28. PubMed ID: 23588991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.
    Krivega I; Byrnes C; de Vasconcellos JF; Lee YT; Kaushal M; Dean A; Miller JL
    Blood; 2015 Jul; 126(5):665-72. PubMed ID: 25979948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genes.
    Cui S; Tanabe O; Sierant M; Shi L; Campbell A; Lim KC; Engel JD
    Blood; 2015 Feb; 125(9):1477-87. PubMed ID: 25561507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reduced curcuminoid analog as a novel inducer of fetal hemoglobin.
    Chaneiam N; Changtam C; Mungkongdee T; Suthatvoravut U; Winichagoon P; Vadolas J; Suksamrarn A; Fucharoen S; Svasti S
    Ann Hematol; 2013 Mar; 92(3):379-86. PubMed ID: 23079892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.
    Yu L; Jearawiriyapaisarn N; Lee MP; Hosoya T; Wu Q; Myers G; Lim KC; Kurita R; Nakamura Y; Vojtek AB; Rual JF; Engel JD
    Genes Dev; 2018 Dec; 32(23-24):1537-1549. PubMed ID: 30463901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer.
    Tanabe O; Katsuoka F; Campbell AD; Song W; Yamamoto M; Tanimoto K; Engel JD
    EMBO J; 2002 Jul; 21(13):3434-42. PubMed ID: 12093744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BCL11A controls the expression of the human fetal hemoglobin].
    Labie D
    Med Sci (Paris); 2012 Nov; 28(11):923-5. PubMed ID: 23171892
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.
    Chou YC; Chen RL; Lai ZS; Song JS; Chao YS; Shen CK
    Mol Cell Biol; 2015 Jul; 35(14):2541-53. PubMed ID: 25986606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis).
    Rivers A; Vaitkus K; Ibanez V; Ruiz MA; Jagadeeswaran R; Saunthararajah Y; Cui S; Engel JD; DeSimone J; Lavelle D
    Haematologica; 2016 Jun; 101(6):688-97. PubMed ID: 26858356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo.
    Boosalis MS; Castaneda SA; Trudel M; Mabaera R; White GL; Lowrey CH; Emery DW; Mpollo MS; Shen L; Wargin WA; Bohacek R; Faller DV; Perrine SP
    Blood Cells Mol Dis; 2011 Aug; 47(2):107-16. PubMed ID: 21641240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.
    Campbell AD; Cui S; Shi L; Urbonya R; Mathias A; Bradley K; Bonsu KO; Douglas RR; Halford B; Schmidt L; Harro D; Giacherio D; Tanimoto K; Tanabe O; Engel JD
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18808-13. PubMed ID: 22042865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.